Skip to main content
Advertisement
Advertisement

OCUL

OCUL logo

Ocular Therapeutix, Inc.

7.54
USD
Sponsored
+0.03
+0.40%
Oct 09, 16:00 UTC -4
Closed
exchange

After-Market

7.54

0.00
-0.07%

OCUL Earnings Reports

Positive Surprise Ratio

OCUL beat 20 of 43 last estimates.

47%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$14.49M
/
-$0.36
Implied change from Q2 26 (Revenue/ EPS)
+7.50%
/
+2.86%
Implied change from Q3 25 (Revenue/ EPS)
-0.40%
/
-5.26%

Ocular Therapeutix, Inc. earnings per share and revenue

On Aug 03, 2026, OCUL reported earnings of -0.35 USD per share (EPS) for Q2 26, beating the estimate of -0.40 USD, resulting in a 13.24% surprise. Revenue reached 13.47 million, compared to an expected 13.46 million, with a 0.09% difference. The market reacted with a +2.82% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of -0.36 USD, with revenue projected to reach 14.49 million USD, implying an increase of 2.86% EPS, and increase of 7.50% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NanoViricides Inc.
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$0.10
Actual
-$0.10
Surprise
+1.96%
FAQ
For Q2 2026, Ocular Therapeutix, Inc. reported EPS of -$0.35, beating estimates by 13.24%, and revenue of $13.47M, 0.09% above expectations.
The stock price moved up 2.82%, changed from $8.17 before the earnings release to $8.40 the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 9 analysts, Ocular Therapeutix, Inc. is expected to report EPS of -$0.36 and revenue of $14.49M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement